Trial Condition(s):
Open study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
11878
Not Available
Not Available
The purpose of this study is to assess the effect on reduction of serum phosphate and the safety of BAY77-1931 (lanthanum carbonate) in patients with hyperphosphatemia undergoing continuous ambulatory peritoneal dialysis.
- Serum phosphate levels: >5.0 mg/dL and <11.0 mg/dL 2 weeks after the initiation of the washout period - Out-patient - Undergoing CAPD for at least previous 3 consecutive months
- Who may not enable to continue CAPD - Serum phosphate levels of >=10.0 mg/dL at the start of the washout period or >=11.0 mg/dL 2 week after - Corrected serum calcium level of <7.0 mg/dL at the start of the washout period or >=11.0 mg/dL 2 week after - Serum intact PTH (Parathyroid) of >=1000 pg/mL at the start of the washout period - Pregnant woman, or lactating mother - Significant gastrointestinal disorders including known acute peptic ulcer - Liver dysfunction - History of cardiovascular or cerebrovascular diseases
Locations | Status | |
---|---|---|
Locations Kitasaito Hospital Asahikawa, Japan, 070-0030 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Eijinkai Hospital Osaki, Japan, 989-6117 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Sendai Shakaihoken Hospital Sendai, Japan, 981-0912 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Tokyo Kyosai Hospital Meguro-ku, Japan, 153-0061 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Shonan Kamakura General Hospital Kamakura, Japan, 247-0072 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Yokosuka Kyosai Hospital Yokosuka, Japan, 238-0011 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Gifu Prefectural General Medical Center Gifu, Japan, 500-8717 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Okayama Saiseikai General Hospital Okayama, Japan, 700-0013 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Tsuchiya General Hospital Hiroshima, Japan, 730-8655 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kawashima Hospital Tokushima, Japan, 770-0011 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Fukuoka Red Cross Hospital Fukuoka, Japan, 815-0082 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Phase III open study of BAY 77 1931 (Lanthanum Carbonate) in patients with hyperphosphatemia undergoing continuous ambulatory peritoneal dialysis (CAPD)
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1